We are live on ! Find out more
Jacobs Levy Equity Management

Jacobs Levy Equity Management Portfolio holdings

AUM $23.8B
1-Year Est. Return 25.4%
This Fund
S&P 500
This Quarter Est. Return
+3.06%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$4.68B
AUM Growth
-$270M
Cap. Flow
-$364M
Cap. Flow %
-7.78%
Top 10 Hldgs %
11.36%
Holding
1,103
New
193
Increased
369
Reduced
317
Closed
187

Top Buys

Rank Stock Value
1
HUM icon
Humana
HUM
+$25.2M
2
ASH icon
Ashland
ASH
+$17.2M
3
IBM icon
IBM
IBM
+$17.1M
4
MSGS icon
Madison Square Garden
MSGS
+$16.7M
5
VLO icon
Valero Energy
VLO
+$16.1M

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$35.9M
2
QCOM icon
Qualcomm
QCOM
+$29M
3
BCR
CR Bard Inc.
BCR
+$27.5M
4
A icon
Agilent Technologies
A
+$26.4M
5
NOC icon
Northrop Grumman
NOC
+$25.1M

Sector Composition

Rank Sector Weight
1 Technology 19.21%
2 Financials 19.14%
3 Healthcare 11.97%
4 Industrials 11.47%
5 Consumer Discretionary 10.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FENX
1101
DELISTED
Fenix Parts, Inc.
FENX
-11,700
Closed -$18K
DO
1102
DELISTED
Diamond Offshore Drilling
DO
-77,700
Closed -$1.3M
RPRX
1103
DELISTED
Repros Therapeutics Inc.
RPRX
-114,165
Closed -$137K

Similar funds

Jacobs Levy Equity Management's Q2 2017 Portfolio in Review

As of Q2 2017, Jacobs Levy Equity Management held 1,103 positions worth $4.68B, down 5.5% from $4.95B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Jacobs Levy Equity Management withdrew a net $364M in Q2 2017, closing 187 positions and reducing 317 holdings. Its most notable exit was CVS Health, an estimated $35.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Jacobs Levy Equity Management opened a new position in Humana worth $26.8M.

  • Jacobs Levy Equity Management's largest Q2 2017 buy was Humana: 111,320 shares worth $26.8M.
  • Jacobs Levy Equity Management added most to Madison Square Garden in Q2 2017, an estimated $16.7M increase.
  • Jacobs Levy Equity Management's biggest Q2 2017 reduction was Agilent Technologies, cutting an estimated $26.4M.
  • Jacobs Levy Equity Management fully exited CVS Health in Q2 2017, selling an estimated $35.9M.
  • Jacobs Levy Equity Management's ten largest holdings make up 11% of its $4.68B portfolio in Q2 2017.
  • Jacobs Levy Equity Management opened 193 new positions and closed 187 in Q2 2017.
  • Jacobs Levy Equity Management's portfolio value fell 5.5% quarter-over-quarter to $4.68B.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2017, filed 14 Aug 2017.